Shares of RingCentral Inc (NYSE:RNG) rose sharply in pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY26 guidance above estimates.
RingCentral reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.28 per share. The company reported quarterly sales of $676.043 million which beat the analyst consensus estimate of $667.035 million.
RingCentral shares jumped 15% to $91.33 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- 22nd Century Group Inc (NASDAQ:XXII) gained 64.6% to $0.36 in pre-market trading. 22nd Century Group shares dipped over 20% on Thursday after the company reported a quarter-over-quarter increase of its preliminary Q3 net revenue results.
- Lakewood-amedex Biotherapeutics Inc (NASDAQ:LABT) gained 56.8% to $0.77 in pre-market trading. The company recently announced the presentation of preclinical Nu-3 data, with the next catalyst remaining Phase 2a topline results in Q1 2027.
- Hub Cyber Security Ltd (NASDAQ:HUBC) gained 47.2% to $0.30 in pre-market trading after dipping 33% on Thursday.
- Lucid Diagnostics Inc (NASDAQ:LUCD) jumped 26.6% to $0.42 in pre-market trading after the company announced that begun receiving Medicare reimbursement payments for its EsoGuard Esophageal DNA Test
- Tantech Holdings Ltd (NASDAQ:TANH) gained 26.1% to $31.30 in pre-market trading after jumping 87% on Thursday.
- Aardvark Therapeutics Inc (NASDAQ:AARD) rose 20.7% to $4.77 in pre-market trading after the clinical-stage biopharmaceutical said the Food and Drug Administration lifted the clinical hold on its Prader-Willi Syndrome (PWS) drug candidate.
- Hyperscale Data Inc (NYSE:GPUS) gained 17.8% to $0.15 in pre-market trading after the AI data center company suspended its at-the-market (ATM) stock offering.
- PAVmed Inc (NASDAQ:PAVM) rose 16.9% to $2.40 in pre-market trading as the company announced that it has begun receiving payments from Medicare for its EsoGuard Esophageal DNA Test.
- Maxlinear Inc (NASDAQ:MXL) gained 10.1% to $71.86 in pre-market trading as the company reported upbeat earnings for the third quarter.
Losers
- Lunai Bioworks Inc (NASDAQ:LNAI) fell 36.2% to $0.30 in pre-market trading after the company announced receipt of Nasdaq determination and intention to voluntarily delist and deregister.
- BranchOut Food Inc. (NASDAQ:BOF) fell 14.4% to $1.73 in pre-market trading after announcing a proposed public offering.
- Pomdoctor Limited (NASDAQ:POM) fell 13.4% to $1.76 in pre-market trading after dipping 33% on Thursday.
- Darkiris Inc. (NASDAQ:DKI) fell 12.8% to $1.9599 in pre-market trading after gaining around 13% on Thursday.
- Enlivex Ltd. (NASDAQ:ENLV) fell 11.6% to $0.1760 in pre-market trading. Enlivex disclosed a 1-for-16 reverse share split to be effective Oct. 27.
- BayCom Corp (NASDAQ:BCML) tumbled 11.4% to $28.23 in pre-market trading after posting weak quarterly results.
- Eason Technology Limited (NYSE:DXF) fell 11.2% to $0.3019 in pre-market trading. Eason Technology announced that its subsidiary, Four Ele Industry, has been granted a patent for an industrial park smart grid dispatch system.
- High Roller Technologies, Inc. (NYSE:ROLR) fell 10.6% to $4.44 in pre-market trading. High Roller Technologies recently announced the commercial launch of its real-money prediction markets platform ROLR.
- Nyxoah SA (NASDAQ:NYXH) declined 10.4% to $0.7356 in pre-market trading. Nyxoah recently lowered its FY26 revenue guidance.
- Deckers Outdoor Corporation (NYSE:DECK) fell 9.1% to $77.50 in pre-market trading after the company reported mixed second-quarter financial results and cut its FY27 sales guidance below estimates.
Photo via Shutterstock
Recent Comments